Todd Harris, Ph.D., is the Chief Executive Officer at TYRA BIOSCIENCES INC, a precision oncology company focused on developing next-generation therapies for cancer patients. Dr. Harris brings a wealth of experience in the biotechnology industry, with a strong background in drug discovery and development. Before joining TYRA BIOSCIENCES, he held several leadership positions at leading biotech companies, where he played a crucial role in advancing innovative cancer treatments from the laboratory to clinical trials. At TYRA BIOSCIENCES, Dr. Harris is responsible for overseeing the company's strategic direction and growth. Under his leadership, the company has made significant progress in its mission to develop targeted therapies for patients with genetically defined cancers. Dr. Harris has been instrumental in building a talented team of scientists and researchers, fostering a collaborative environment that encourages innovation and excellence. His vision and dedication have been key factors in the company's success, as it continues to advance its pipeline of promising drug candidates. Throughout his career, Dr. Harris has been recognized for his contributions to the field of oncology. He has authored numerous scientific publications and has been an invited speaker at various international conferences. His expertise in precision medicine and his commitment to improving patient outcomes have earned him respect and admiration from his peers in the industry. As CEO of TYRA BIOSCIENCES, Dr. Harris remains focused on translating cutting-edge research into effective treatments that can make a meaningful difference in the lives of cancer patients.